Patent · US Expired

PSCA: prostate stem cell antigen and uses thereof

US6825326B2 · kind B2 · utility

19Cited by

3References

23Claims

0Family size

Assignee

The Regents of the University of California · US

Inventors

Robert E. Reiter · Los Angeles, US
Owen N. Witte · West Hollywood, US

Key dates

Filing date	Aug 21, 2001
Grant date	Nov 30, 2004
Priority date	—
Expiry date	Aug 21, 2021

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/705
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides a novel prostate cell-surface antigen, designated Prostate Stem Cell Antigen (PSCA), which is widely over-expressed across all stages of prostate cancer, including high grade prostatic intraepithelial neoplasia (PIN), androgen-dependent and androgen-independent prostate tumors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.